Application of Antisense Conjugates for the Treatment of Myotonic Dystrophy Type 1. (2023)

First Author: Stoodley J
Attributed to:  Advanced peptide-oligonucleotide therapy for Myotonic Dystrophy Type 1 funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3390/ijms24032697

PubMed Identifier: 36769018

Publication URI: http://europepmc.org/abstract/MED/36769018

Type: Journal Article/Review

Volume: 24

Parent Publication: International journal of molecular sciences

Issue: 3

ISSN: 1422-0067